Published in

Lippincott, Williams & Wilkins, Clinical Nuclear Medicine, 6(40), p. 492-493, 2015

DOI: 10.1097/rlu.0000000000000747

Links

Tools

Export citation

Search in Google Scholar

Anakinra injection site reaction on FDG PET/CT

Journal article published in 2015 by Anne I. J. Arens, Dennis Vriens ORCID, Marijn Janssen, Anna Simon, Wim J. G. Oyen
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Adult-onset Still's disease (AOSD) is a rare inflammatory disorder of unknown etiology, mainly characterized by fever, arthritis, skin rash, and raised ferritin concentration. FDG PET/CT scan of a 29-year-old woman with AOSD showed extensive lymphadenopathy, hypermetabolic splenomegaly, and increased bone marrow uptake consistent with AOSD activity. In addition, large dense lesions with high FDG uptake in the subcutaneous fat in the thighs corresponding to injection sites were seen. She had been treated with prednisone and daily subcutaneous injection of 100 mg anakinra before the scan indicating the subcutaneous lesions as injection site reactions to anakinra.